BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9

• Press Releases

  Spruce Biosciences to Present at Upcoming Investor Conferences in March 2026

  March 3, 2026

   · 

  1 min read
• Press Releases

  Bristol Myers Squibb Announces Dividend - March 2, 2026

  March 3, 2026

   · 

  1 min read
• Press Releases

  Fagron completes acquisition of Vepakum

  March 3, 2026

   · 

  1 min read
• Press Releases

  Montis Biosciences Advances First-in-Class Dual-Action C1q Antibody with Strong Preclinical Proof-of-Concept in Neuroinflammatory Diseases

  March 3, 2026

   · 

  4 min read
• Press Releases

  SNIPR announces Publication of Final Positive Phase 1 Results for SNIPR001 in The Lancet Microbe

  March 3, 2026

   · 

  4 min read
• Press Releases

  MindMaze Therapeutics Provides Corporate Update and Publishes March 2026 Investor Presentation

  March 3, 2026

   · 

  4 min read
• Press Releases

  SHERPA research consortium initiates seven clinical studies to validate AI-based assistive technologies for minimally invasive brain and cancer treatments

  March 3, 2026

   · 

  8 min read
• Press Releases

  Quell Therapeutics Demonstrates Safety, Phenotypic Stability, Durability and Early Efficacy with Phenotype‑Locked™ CAR‑Tregs in LIBERATE Phase 1/2 Liver Transplant Study

  March 3, 2026

   · 

  5 min read
• Press Releases

  Quell Therapeutics Initiates CHILL Phase 1/2 Trial of Novel QEL-005 CAR-Treg Therapy in Refractory Rheumatoid Arthritis and Systemic Sclerosis Following UK CTA Approval

  March 3, 2026

   · 

  5 min read
• Press Releases

  Greenwich LifeSciences Provides Update on Increased Patient Screen Rate in FLAMINGO-01

  March 3, 2026

   · 

  7 min read